1,010
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2

, , , , & ORCID Icon
Pages 6629-6640 | Received 22 Dec 2021, Accepted 15 Feb 2022, Published online: 25 Feb 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yunchao Xin, Xiaoling Shang, Xiaoran Sun, Guogang Xu, Yachao Liu & Yanbin Liu. (2022) SLC8A1 antisense RNA 1 suppresses papillary thyroid cancer malignant progression via the FUS RNA binding protein (FUS)/NUMB like endocytic adaptor protein (Numbl) axis. Bioengineered 13:5, pages 12572-12582.
Read now

Articles from other publishers (3)

Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, Timo L.M. ten Hagen, Shokooh Salimimoghadam, Afshin Taheriazam, Maliheh Entezari & Mojtaba Falahati. (2023) HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response. Pharmacological Research 190, pages 106732.
Crossref
Vahid Asghariazar, Behzad Mansoori, Mahtab Kadkhodayi, Elham Safarzadeh, Ali Mohammadi, Behzad Baradaran & Ebrahim Sakhinia. (2022) MicroRNA-143 act as a tumor suppressor microRNA in human lung cancer cells by inhibiting cell proliferation, invasion, and migration. Molecular Biology Reports 49:8, pages 7637-7647.
Crossref
Rubai Ahmed, Sovan Samanta, Jhimli Banerjee, Suvrendu Sankar Kar & Sandeep Kumar Dash. (2022) Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation. Current Research in Pharmacology and Drug Discovery 3, pages 100131.
Crossref